financetom
SBR
financetom
/
Energy
/
SBR
All stocks News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Commodities
Sabine Royalty TrustSBR
USD
- At close
USD
- Until the end
The complete list of US stocks
1D
5D
1M
1Y
5Y
MAX
Overview >
% Change
Description >

Sabine Royalty Trust holds royalty and mineral interests in various producing oil and gas properties in the United States.

Its royalty and mineral interests include landowner's royalties, overriding royalty interests, minerals, production payments, and other similar non-participatory interest in certain producing and proved undeveloped oil and gas properties located in Florida, Louisiana, Mississippi, New Mexico, Oklahoma, and Texas.

The company was founded in 1982 and is based in Dallas, Texas.

Latest News >
ADF Group Reports Higher Profit, Revenue for Fiscal 2024; to Pay Semi-Annual Dividend
ADF Group Reports Higher Profit, Revenue for Fiscal 2024; to Pay Semi-Annual Dividend
Apr 11, 2024
08:57 AM EDT, 04/11/2024 (MT Newswires) -- ADF Group Inc. ( ADFJF ) , which makes steel structures and components for the construction industry on Thursday reported a more than doubling in net income for the fiscal year ended Jan. 31, 2024. Net income rose to $37.6 million, or $1.15 per basic and diluted share, up from near $15 million,...
Fiverr Board Authorizes $100 Million Stock Repurchase Plan
Fiverr Board Authorizes $100 Million Stock Repurchase Plan
Apr 11, 2024
08:58 AM EDT, 04/11/2024 (MT Newswires) -- Fiverr International ( FVRR ) said Thursday its board authorized on April 1 the repurchase of up to $100 million of the company's ordinary shares. The company's creditors may apply and object regarding the stock buyback plan until May 4, subject to court approval, Fiverr ( FVRR ) added. The share repurchase plan...
Vertex Pharmaceuticals Moves Beyond $10B Cystic Fibrosis Franchise, Pays Around $5B For Kidney Disease Player Alpine Immune
Vertex Pharmaceuticals Moves Beyond $10B Cystic Fibrosis Franchise, Pays Around $5B For Kidney Disease Player Alpine Immune
Apr 11, 2024
On Wednesday, Vertex Pharmaceuticals Incorporated ( VRTX ) agreed to acquire Alpine Immune Sciences Inc ( ALPN ) for $65 per share or approximately $4.9 billion in cash.  Alpine’s lead molecule, povetacicept (ALPN-303), is a highly potent and effective dual antagonist of BAFF (B cell activating factor) and APRIL (a proliferation inducing ligand).  Through Phase 2 development, povetacicept has shown potential best-in-class efficacy in IgA...
Market Chatter: Spotify Technology Developing Editing Tools for Users
Market Chatter: Spotify Technology Developing Editing Tools for Users
Apr 11, 2024
08:58 AM EDT, 04/11/2024 (MT Newswires) -- Spotify Technology ( SPOT ) is developing tools that would allow subscribers to edit songs from their favorite artists, The Wall Street Journal reported Thursday, citing people familiar with the discussions. The new tools the audio-streaming company is considering include a playback feature that would allow users to adjust the speed of a...
Copyright 2023-2026 - www.financetom.com All Rights Reserved